Targeted intraoperative radiation therapy (IORT) as an alternative to whole breast irradiation (WBI) has been described for patients with early-stage breast cancer. The randomized phase III TARGiT trial demonstrated similar recurrence rates to WBI and a lower overall toxicity profile on short-term follow-up. We report on our early North American surgical experience using the Intrabeam radiotherapy delivery system and review the current literature.
Methods
Prospectively gathered estrogen receptor-positive, clinically node-negative patients with invasive breast cancer < 3 cm receiving IORT using the Intrabeam system were reviewed. IORT-related effects and early postoperative outcome were assessed. A literature review was also performed.
Results
Forty-two patients (median age 71 years) underwent lumpectomy, sentinel lymph node (SLN) biopsy, and concurrent IORT from January 2011 to July 2011. Ninety-one percent of patients had invasive ductal histology with a median tumor size of 1.0 cm. This review highlights the patient selection criteria, describes commercially available accelerated partial breast irradiation (APBI) treatment options, and discusses outcomes for the variety of APBI techniques currently utilized in clinical practice as well as an istitutional review of our early surgical experience using the Intrabeam radiotherapy delivery system.
Conclusions
While a variety of APBI techniques are currently available for clinical use, our early North American operative experience with IORT shows it is well tolerated with low morbidity. Delivery of IORT adds moderate operative time and may require creating subcutaneous tissue flaps. The addition of WBI may be necessary in situations for positive residual margins or microscopic nodal disease in patients who do not undergo additional surgery.
References
1.
ClarkeM., CollinsR., DarbyS.. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.Lancet.2005; 366(9503): 2087–2106.
2.
van DongenJ.A., VoogdA.C., FentimanI.S.. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.J Natl Cancer Inst.2000; 92(14): 1143–1150.
3.
FisherB., AndersonS., BryantJ.. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med.2002; 347(16): 1233–1241.
4.
VeronesiU., CascinelliN., MarianiL.. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.N Engl J Med.2002; 347(16): 1227–1232.
5.
BartelinkH., HoriotJ.C., PoortmansP.M.. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.J Clin Oncol.2007; 25(22): 3259–3265.
6.
BelkacemiY., ChauvetM.P., GiardS.. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study.Radiother Oncol.2009; 90(1): 23–29.
7.
BenitezP.R., KeischM.E., ViciniF.. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.Am J Surg.2007; 194(4): 456–462.
8.
PolgárC., FodorJ., MajorT.. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma–5-year results of a randomized trial.Int J Radiat Oncol Biol Phys.2007; 69(3): 694–702.
9.
VaidyaJ.S., TobiasJ.S., BaumM.. TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation.Semin Radiat Oncol.2005; 15(2): 84–91.
10.
PolgárC., StrnadV., MajorT.. Brachytherapy for partial breast irradiation: the European experience.Semin Radiat Oncol.2005; 15(2): 116–122.
11.
ViciniF.A., ArthurD.W.. Breast brachytherapy: North American experience.Semin Radiat Oncol.2005; 15(2): 108–115.
12.
ClarkeD.H., LeM.G., SarrazinD.. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy.Int J Radiat Oncol Biol Phys.1985; 11(1): 137–145.
13.
MorrowM.. Rational local therapy for breast cancer.N Engl J Med.2002; 347(16): 1270–1271.
14.
PolgárC., MajorT.. Current status and perspectives of brachytherapy for breast cancer.Int J Clin Oncol.2009; 14(1): 7–24.
15.
FentimanI.S., PooleC., TongD.. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer.Eur J Cancer.1996; 32A(4): 608–611.
16.
MageeB., SwindellR., HarrisM.. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial.Radiother Oncol.1996; 39(3): 223–227.
17.
PotiZ., NemeskeriC., FekeshazyA.. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.Int J Radiat Oncol Biol Phys.2004; 58(4): 1022–1033.
18.
PereraF., YuE., EngelJ.. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years’ minimum follow-up.Int J Radiat Oncol Biol Phys.2003; 57(5): 1239–1246.
19.
ViciniF., ArthurD., PolgárC.. Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, optimal quality assurance, and common sense.Int J Radiat Oncol Biol Phys.2003; 57(5): 1210–1213.
20.
DodwellD.J., DykerK., BrownJ.. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer.Clin Oncol (R Coll Radiol).2005; 17(8): 618–622.
21.
KrishnanL., JewellW.R., TawfikO.W.. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer.Breast J.2001; 7(2): 91–96.
22.
NiehoffP., PolgárC., OstertagH.. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial.Radiother Oncol.2006; 79(3): 316–320.
23.
OttO.J., HildebrandtG., PotterR.. Accelerated partial breast irradiation with multicatheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multicentre trial.Ra- diother Oncol.2007; 82(3): 281–286.
24.
PolgárC., MajorT., FodorJ.. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.Int J Radiat Oncol Biol Phys.2004; 60(4): 1173–1181.
25.
WazerD.E., KaufmanS., CuttinoL.. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.Int J Radiat Oncol Biol Phys.2006; 64(2): 489–495.
26.
KingT.A., BoltonJ.S., KuskeR.R.. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer.Am J Surg.2000; 180(4): 299–304.
27.
Gomez-IturriagaA., PinaL., CambeiroM.. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy.Brachytherapy.2008; 7(4): 310–315.
28.
PatelR.R., ChristensenM.E., HodgeC.W.. Clinical outcome analysis in “high-risk” versus “low-risk” patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results.Int J Radiat Oncol Biol Phys.2008; 70(4): 970–973.
29.
SmithB.D., ArthurD.W., BuchholzT.A.. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).Int J Radiat Oncol Biol Phys.2009; 74(4): 987–1001.
30.
PolgárC., FodorJ., MajorT.. The role of boost irradiation in the conservative treatment of stage I-II breast cancer.Pathol Oncol Res.2001; 7(4): 241–250.
31.
PolgárC., FodorJ., OroszZ.. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.Strahlenther Onkol.2002; 178(11): 615–623.
32.
AnscherM.S., JonesP., ProsnitzL.R.. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy.Ann Surg.1993; 218(1): 22–28.
33.
SchnittS.J., AbnerA., GelmanR.. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy.Cancer.1994; 74(6): 1746–1751.
34.
FentimanI.S., DeshmaneV., TongD.. Caesium(137) implant as sole radiation therapy for operable breast cancer: a phase II trial.Radiother Oncol.2004; 71(3): 281–285.
35.
JohanssonB., KarlssonL., LiljegrenG.. Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1-T2 breast cancer: first long time results from a clinical study.Radiother Oncol.2009; 90(1): 30–35.
36.
ArthurD.W., WinterK., KuskeR.R.. A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17.Int J Radiat Oncol Biol Phys.2008; 72(2): 467–473.
37.
AntonucciJ.V., WallaceM., GoldsteinN.S.. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.Int J Radiat Oncol Biol Phys.2009; 74(2): 447–452.
38.
RakovitchE., PignolJ.P., HannaW.. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy.J Clin Oncol.2007; 25(35): 5591–5596.
39.
ViciniF., BeitschP.D., QuietC.A.. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).Cancer.2008; 112(4): 758–766.
40.
van LimbergenE., van den BogaertW., van der SchuerenE.. Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control.Radiother Oncol.1987; 8(1): 1–9.
41.
ElkhuizenP.H., van de VijverM.J., HermansJ., ZonderlandH.M., van de VeldeC.J., LeerJ.W.. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival.Int J Radiat Oncol Biol Phys.1998; 40(4): 859–867.
42.
de la RochefordiereA., AsselainB., CampanaF.. Age as prognostic factor in premenopausal breast carcinoma.Lancet.1993; 341(8852): 1039–1043.
43.
ChaoK.K., ViciniF.A., WallaceM.. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.Int J Radiat Oncol Biol Phys.2007; 69(1): 32–40.
44.
NoseT., KomoikeY., YoshidaK.. A pilot study of wider use of accelerated partial breast irradiation: intraoperative margin-directed reexcision combined with sole high-dose-rate interstitial brachytherapy.Breast Cancer.2006; 13(3): 289–299.
45.
VaidyaJ.S., BaumM., TobiasJ.S.. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.Int J Radiat Oncol Biol Phys.2006; 66(5): 1335–1338.
46.
PolgárC., Van LimbergenE., PotterR.. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009).Radiother Oncol.2010; 94(3): 264–273.
47.
SundquistM., ThorstensonS., KlintenbergC.. Indicators of locoregional recurrence in breast cancer. The South East Swedish Breast Cancer Group.Eur J Surg Oncol.2000; 26(4): 357–362.
48.
ZellarsR.C., HilsenbeckS.G., ClarkG.M.. Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients.J Clin Oncol.2000; 18(9): 1906–1913.
49.
FisherB.J., PereraF.E., CookeA.L.. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.Int J Radiat Oncol Biol Phys.1998; 42(1): 117–123.
50.
Piccart-GebhartM.J., ProcterM., Leyland-JonesB.. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.N Engl J Med.2005; 353(16): 1659–1672.
51.
GreeneF.L., PageD.L., FlemingI.D.. AJCC Cancer Staging Handbook.6th ed.New York, NY: Springer; 2002.
52.
Schmidt-UllrichP.N., TodorD.A., CuttinoL.W.. Virtual planning of multicatheter brachytherapy implants for accelerated partial breast irradiation.Conf Proc IEEE Eng Med Biol Soc.2004; 5: 3124–3127.
53.
ArthurD.W., KooD., ZwickerR.D.. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience.Int J Radiat Oncol Biol Phys.2003; 56(3): 681–689.
54.
OttO.J., PotterR., HammerJ.. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial.Strahlenther Onkol.2004; 180(10): 642–649.
55.
SandersM.E., ScrogginsT., AmpilF.L.. Accelerated partial breast irradiation in early-stage breast cancer.J Clin Oncol.2007; 25(8): 996–1002.
56.
ViciniF.A., KestinL., ChenP.. Limited-field radiation therapy in the management of early-stage breast cancer.J Natl Cancer Inst.2003; 95(16): 1205–1210.
57.
LawendaB.D., TaghianA.G., KachnicL.A.. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant.Int J Radiat Oncol Biol Phys.2003; 56(3): 671–680.
58.
StrnadV., HildebrandtG., PotterR.. Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery.Int J Radiat Oncol Biol Phys.2011; 80(1): 17–24.
59.
KeischM., ViciniF., KuskeR.R.. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy.Int J Radiat Oncol Biol Phys.2003; 55(2): 289–293.
60.
BartelinkH.. Commentary on the paper “A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated”. A critical review of an innovative approach.Eur J Cancer.2001; 37(17): 2143–2146.
61.
JerussJ.S., KuererH.M., BeitschP.D.. Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial.Ann Surg Oncol.2011; 18(1): 65–71.
62.
ChenS., DicklerA., KirkM.. Patterns of failure after MammoSite brachytherapy partial breast irradiation: a detailed analysis.Int J Radiat Oncol Biol Phys.2007; 69(1): 25–31.
63.
KhanA.J., ArthurD., ViciniF.. Six-Year analysis of treatment-related toxicities in patients treated with accelerated partial breast irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial.Ann Surg Oncol.2012; 19(5): 1477–1483.
64.
ViciniF., BeitschP., QuietC.. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation.Int J Radiat Oncol Biol Phys.2011; 79(3): 808–817.
65.
DragunA.E., HarperJ.L., JenretteJ.M.. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up.Int J Radiat Oncol Biol Phys.2007; 68(2): 354–358.
66.
HaleyM., BeriwalS., HeronD.E.. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup.Brachytherapy.2009; 8(1): 9–13.
67.
WatkinsJ.M., HarperJ.L., DragunA.E.. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy.Brachytherapy.2008; 7(4): 305–309.
68.
DicklerA., PatelR.R., WazerD.. Breast brachytherapy devices.Expert Rev Med Devices.2009; 6(3): 325–333.
69.
TokitaK.M., CuttinoL.W., ViciniF.A.. Optimal application of the Contura multilumen balloon breast brachytherapy catheter vacuum port to deliver accelerated partial breast irradiation.Brachytherapy.2011; 10(3): 184–189.
70.
BrownS., McLaughlinM., PopeK.. Initial radiation experience evaluating early tolerance and toxicities in patients undergoing accelerated partial breast irradiation using the Contura Multi-Lumen Balloon breast brachytherapy catheter.Brachytherapy.2009; 8(2): 227–233.
71.
IsraelP.Z., RobbinsA., ShroffP.. Three-year clinical outcome using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation (APBI): improving radiation standards for the optimal application of APBI.Brachytherapy.2012; 11(4): 316–321.
72.
BeriwalS., CoonD., KimH.. Multicatheter hybrid breast brachytherapy: a potential alternative for patients with inadequate skin distance.Brachy- therapy.2008; 7(4): 301–304.
73.
DicklerA., SeifN., KirkM.C.. A dosimetric comparison of MammoSite and ClearPath high-dose-rate breast brachytherapy devices.Brachytherapy.2009; 8(1): 14–18.
74.
YasharC.M., BlairS., WallaceA.. Initial clinical experience with the Strut-Adjusted Volume Implant brachytherapy applicator for accelerated partial breast irradiation.Brachytherapy.2009; 8(4): 367–372.
75.
ScanderbegD.J., YasharC., RiceR.. Clinical implementation of a new HDR brachytherapy device for partial breast irradiation.Radiother Oncol.2009; 90(1): 36–42.
76.
YasharC.M., ScanderbegD., KuskeR.. Initial clinical experience with the Strut-Adjusted Volume Implant (SAVI) breast brachytherapy device for accelerated partial-breast irradiation (APBI): first 100 patients with more than 1 year of follow-up.Int J Radiat Oncol Biol Phys.2011; 80(3): 765–770.
77.
ViciniF., WinterK., StraubeW.. A phase I/II trial to evaluate threedimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.Int J Radiat Oncol Biol Phys.2005; 63(5): 1531–1537.
VeronesiU., MarubiniE., MarianiL.. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial.Ann Oncol.2001; 12(7): 997–1003.
80.
FormentiS.C., TruongM.T., GoldbergJ.D.. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis.Int J Radiat Oncol Biol Phys.2004; 60(2): 493–504.
81.
CoxB.W., HorstK.C., ThorntonS.. Impact of increasing margin around the lumpectomy cavity to define the planning target volume for 3D conformal external beam accelerated partial breast irradiation.Med Dosim.2007; 32(4): 254–262.
82.
ChenP.Y., WallaceM., MitchellC.. Four-year efficacy, cosmesis, and toxicity using threedimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.Int J Radiat Oncol Biol Phys.2010; 76(4): 991–997.
83.
ViciniF., WinterK., WongJ.. Initial efficacy results of RTOG 0319: threedimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma.Int J Radiat Oncol Biol Phys.2010; 77(4): 1120–1127.
84.
KozakK.R., DoppkeK.P., KatzA.. Dosimetric comparison of two different threedimensional conformal external beam accelerated partial breast irradiation techniques.Int J Radiat Oncol Biol Phys.2006; 65(2): 340–346.
85.
QiuJ.J., ChangZ., WuQ.J.. Impact of volumetric modulated arc therapy technique on treatment with partial breast irradiation.Int J Radiat Oncol Biol Phys.2010; 78(1): 288–296.
86.
ShaitelmanS.F., KimL.H., YanD.. Continuous arc rotation of the couch therapy for the delivery of accelerated partial breast irradiation: a treatment planning analysis.Int J Radiat Oncol Biol Phys.2011; 80(3): 771–778.
87.
HamidS., RocchioK., ArthurD.. A Multi-Institutional Study of Feasibility, Implementation, and Early Clinical Results with Noninvasive Breast Brachytherapy for Tumor Bed Boost.Int J Radiat Oncol Biol Phys.2012; 83(5): 1374–1380.
88.
YangY., RivardM.J.. Monte Carlo simulations and radiation dosimetry measurements of peripherally applied HDR 192Ir breast brachytherapy D-shaped applicators.Med Phys.2009; 36(3): 809–815.
89.
WangX., AmosR.A., ZhangX.. External-beam accelerated partial breast irradiation using multiple proton beam configurations.Int J Radiat Oncol Biol Phys.2011; 80(5): 1464–1472.
90.
LemanskiC., AzriaD., Gourgon-BourgadeS.. Intraoperative radiotherapy in early-stage breast cancer: results of the montpellier phase II trial.Int J Radiat Oncol Biol Phys.2010; 76(3): 698–703.
VaidyaJ.S., JosephD.J., TobiasJ.S.. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.Lancet.2010; 376(9735): 91–102.
93.
KimpleR.J., Klauber-DeMoreN., KuzmiakC.M.. Cosmetic outcomes for accelerated partial breast irradiation before surgical excision of early-stage breast cancer using single-dose intraoperative radiotherapy.Int J Radiat Oncol Biol Phys.2011; 79(2): 400–407.
94.
CioccaM., OrecchiaR., GaribaldiC.. In vivo dosimetry using radiochro-mic films during intraoperative electron beam radiation therapy in early-stage breast cancer.Radiother Oncol.2003; 69(3): 285–289.
95.
DicklerA., IvanovO., FrancescattiD.. Intraoperative radiation therapy in the treatment of early-stage breast cancer utilizing xoft axxent electronic brachy- therapy.World J Surg Oncol.2009; 7: 24.
96.
IvanovO., DicklerA., LumB.Y.. Twelve-month follow-up results of a trial utilizing Axxent electronic brachytherapy to deliver intraoperative radiation therapy for early-stage breast cancer.Ann Surg Oncol.2011; 18(2): 453–458.
97.
DicklerA., KirkM.C., SeifN.. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy.Brachytherapy.2007; 6(2): 164–168.
98.
MehtaV.K., AlganO., GriemK.L.. Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation.Am J Clin Oncol.2010; 33(4): 327–335.
99.
DooleyW.C., WurzerJ.C., MegahyM.. Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis.Onco Targets Ther.2011; 4: 13–20.
100.
VaidyaJ.S., BaumM., TobiasJ.S.. Targeted intraoperative radiotherapy (Targit): an innovative method of treatment for early breast cancer.Ann Oncol.2001; 12(8): 1075–1080.
101.
DouglasR.M., BeattyJ., GallK.. Dosimetric results from a feasibility study of a novel radiosurgical source for irradiation of intracranial metastases.Int J Radiat Oncol Biol Phys.1996; 36(2): 443–450.
102.
CosgroveG.R., HochbergF.H., ZervasN.T.. Interstitial irradiation of brain tumors, using a miniature radiosurgery device: initial experience.Neurosurgery.1997; 40(3): 518–523; discussion 523-515.
103.
VaidyaJ.S., TobiasJ.S., BaumM.. Intraoperative radiotherapy for breast cancer.Lancet Oncol.2004; 5(3): 165–173.
104.
VaidyaJ.S., BaumM., TobiasJ.S.. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer.Eur J Surg Oncol.2002; 28(4): 447–454.
105.
HerskindC., GriebelJ., Kraus-TiefenbacherU.. Sphere of equivalence: a novel target volume concept for intraoperative radiotherapy using low-energy X rays.Int J Radiat Oncol Biol Phys.2008; 72(5): 1575–1581.
106.
WenzF., WelzelG., KellerA.. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer.Breast.2008; 17(6): 617–622.
107.
AndersenK.G., GartnerR., KromanN.. Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: a randomized trial.Breast.2012; 21(1): 46–49.
